Hospital Capacity during an Influenza Pandemic—Buenos Aires, Argentina, 2009

2011 ◽  
Vol 32 (1) ◽  
pp. 87-90 ◽  
Author(s):  
Elissa Meites ◽  
Daniel Farias ◽  
Lucrecia Raffo ◽  
Rachel Albalak ◽  
Oreste Luis Carlino ◽  
...  

At a major referral hospital in the Southern Hemisphere, the 2009 influenza A (H1N1) pandemic brought increased critical care demand and more unscheduled nursing absences. Because of careful preparedness planning, including rapid expansion and redistribution of the numbers of available beds and staff, hospital surge capacity was not exceeded.

Author(s):  
Jun Cai ◽  
Bo Xu ◽  
Karen Kie Yan Chan ◽  
Xueying Zhang ◽  
Bing Zhang ◽  
...  

There is increasing concern about another influenza pandemic in China. However, the understanding of the roles of transport modes in the 2009 influenza A(H1N1) pandemic spread across mainland China is limited. Herein, we collected 127,797 laboratory-confirmed cases of influenza A(H1N1)pdm09 in mainland China from May 2009 to April 2010. Arrival days and peak days were calculated for all 340 prefectures to characterize the dissemination patterns of the pandemic. We first evaluated the effects of airports and railway stations on arrival days and peak days, and then we applied quantile regressions to quantify the relationships between arrival days and air, rail, and road travel. Our results showed that early arrival of the virus was not associated with an early incidence peak. Airports and railway stations in prefectures significantly advanced arrival days but had no significant impact on peak days. The pandemic spread across mainland China from the southeast to the northwest in two phases that were split at approximately 1 August 2009. Both air and road travel played a significant role in accelerating the spread during phases I and II, but rail travel was only significant during phase II. In conclusion, in addition to air and road travel, rail travel also played a significant role in accelerating influenza A(H1N1)pdm09 spread between prefectures. Establishing a multiscale mobility network that considers the competitive advantage of rail travel for mid to long distances is essential for understanding the influenza pandemic transmission in China.


PLoS Currents ◽  
2009 ◽  
Vol 1 ◽  
pp. RRN1133 ◽  
Author(s):  
Duygu Balcan ◽  
Vittoria Colizza ◽  
Andrew C. Singer ◽  
Christos Chouaid ◽  
Hao Hu ◽  
...  

2018 ◽  
Vol 13 (03) ◽  
pp. 582-592 ◽  
Author(s):  
Maaike Droogers ◽  
Massimo Ciotti ◽  
Peter Kreidl ◽  
Angeliki Melidou ◽  
Pasi Penttinen ◽  
...  

AbstractPandemic influenza A (H1N1) commenced in April 2009. Robust planning and preparedness are needed to minimize the impact of a pandemic. This study aims to review if key elements of pandemic preparedness are included in national plans of European countries. Key elements were identified before and during the evaluations of the 2009 pandemic and are defined in this study by 42 items. These items are used to score a total of 28 publicly available national pandemic influenza plans. We found that plans published before the 2009 influenza pandemic score lower than plans published after the pandemic. Plans from countries with a small population size score significantly lower compared to national plans from countries with a big population (P <.05). We stress that the review of written plans does not reflect the actual preparedness level, as the level of preparedness entails much more than the existence of a plan. However, we do identify areas of improvement for the written plans, such as including aspects on the recovery and transition phase and several opportunities to improve coordination and communication, including a description of the handover of leadership from health to wider sector management and communication activities during the pre-pandemic phase. (Disaster Med Public Health Preparedness. 2019;13:582-592)


Membranes ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 491
Author(s):  
Danielle Feldhaus ◽  
Daniel Brodie ◽  
Philippe Lemaitre ◽  
Joshua Sonett ◽  
Cara Agerstrand

Extracorporeal membrane oxygenation (ECMO) has been used with increasing frequency to support patients with acute respiratory failure, most commonly, and severe forms of acute respiratory distress syndrome (ARDS). The marked increase in the global use of ECMO followed the publication of a large randomized trial in 2009 and the experience garnered during the 2009 influenza A (H1N1) pandemic, and has been further supported by the release of a large, randomized clinical trial in 2018, confirming a benefit from using ECMO in patients with severe ARDS. Despite a rapid expansion of ECMO-related publications, optimal management of patients receiving ECMO, in terms of patient selection, ventilator management, anticoagulation, and transfusion strategies, is evolving. Most recently, ECMO is being utilized for an expanding variety of conditions, including for cases of severe pulmonary or cardiac failure from coronavirus disease 2019 (COVID-19). This review evaluates modern evidence for ECMO for respiratory failure and the current challenges in the field.


Viruses ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1145
Author(s):  
Hakimeh Baghaei Daemi ◽  
Muhammad Fakhar-e-Alam Kulyar ◽  
Xinlin He ◽  
Chengfei Li ◽  
Morteza Karimpour ◽  
...  

Influenza is a highly known contagious viral infection that has been responsible for the death of many people in history with pandemics. These pandemics have been occurring every 10 to 30 years in the last century. The most recent global pandemic prior to COVID-19 was the 2009 influenza A (H1N1) pandemic. A decade ago, the H1N1 virus caused 12,500 deaths in just 19 months globally. Now, again, the world has been challenged with another pandemic. Since December 2019, the first case of a novel coronavirus (COVID-19) infection was detected in Wuhan. This infection has risen rapidly throughout the world; even the World Health Organization (WHO) announced COVID-19 as a worldwide emergency to ensure human health and public safety. This review article aims to discuss important issues relating to COVID-19, including clinical, epidemiological, and pathological features of COVID-19 and recent progress in diagnosis and treatment approaches for the COVID-19 infection. We also highlight key similarities and differences between COVID-19 and influenza A to ensure the theoretical and practical details of COVID-19.


2011 ◽  
Vol 44 (3) ◽  
pp. 237-241 ◽  
Author(s):  
Tomas Faresjö ◽  
Lina Arvidsson ◽  
Pontus Boberg ◽  
Britt Hagert ◽  
Elin A. Gursky ◽  
...  

2017 ◽  
Vol 5 (28) ◽  
Author(s):  
Sara Jones ◽  
Raji Prasad ◽  
Anjana S. Nair ◽  
Sanjai Dharmaseelan ◽  
Remya Usha ◽  
...  

ABSTRACT We report here the whole-genome sequence of six clinical isolates of influenza A(H1N1)pdm09, isolated from Kerala, India. Amino acid analysis of all gene segments from the A(H1N1)pdm09 isolates obtained in 2014 and 2015 identified several new mutations compared to the 2009 A(H1N1) pandemic strain.


Sign in / Sign up

Export Citation Format

Share Document